Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is a complex, heterogeneous, inflammatory, chronic auto-immune disease in which the body's immune system attacks its own tissues, leading to widespread damage in various organs, including the kidneys, lungs, heart, ...
from Google Alert - Business https://ift.tt/3lDIWyw
Systemic Lupus Erythematosus (SLE) is a complex, heterogeneous, inflammatory, chronic auto-immune disease in which the body's immune system attacks its own tissues, leading to widespread damage in various organs, including the kidneys, lungs, heart, ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/3lDIWyw
Systemic Lupus Erythematosus (SLE) is a complex, heterogeneous, inflammatory, chronic auto-immune disease in which the body's immune system attacks its own tissues, leading to widespread damage in various organs, including the kidneys, lungs, heart, ... https://ift.tt/eA8V8J
Comments
Post a Comment